2019 is a big year for surgical robotics. For example, the competition is really heating up in the orthopedic surgical robotic space. Zimmer Biomet received FDA approval for its ROSA Total Knee Robotic System. This system will pose a significant challenge to the incumbent on the market, which is Stryker's Mako total new robotic system. Especially because Zimmer Biomet already have a dominant position in the large join implant space.

In the spine market, Medtronic and Mazor Robotics is beginning to realize their synergies following their merger. This is first exemplified by the launch of the Mazor X Stealth Edition which is an upgrade to the existing Mazor X robotics system with an integrated navigation capabilities.

In 2019, we're also seeing robotic surgery penetrating into specialties that was not previously penetrated specifically, endoluminal robotic surgery. Johnson and Johnson acquired Auris Health which is a pioneer of endoluminal surgery. This acquisition adds to Johnson and Johnson's existing technologies in both the abdominal robotic surgery which is in development in collaboration with Google, as well as orthopedic robotic surgery systems, which is acquired through its acquisition of Orthotaxy.

Intuitive Surgical, which is one of the pioneers of robotic surgery as a whole, also entered the endoluminal robotics surgery space through the FDA approval of its Ion robotic surgery system. It is going to be very interesting to see how the endoluminal robotic surgery market shape up in the future, seeing these two medical device giants enter the space.

A look ahead: Medical aesthetics market recovery in 2021 and beyond

View Now